4//SEC Filing
FOLETTA MARK G 4
Accession 0001062993-25-005503
CIK 0001177648other
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 5:34 PM ET
Size
8.6 KB
Accession
0001062993-25-005503
Insider Transaction Report
Form 4
FOLETTA MARK G
Director
Transactions
- Award
Stock Option (right to buy)
2025-03-13+15,700→ 15,700 totalExercise: $6.83Exp: 2035-03-13→ Common Stock (15,700 underlying)
Footnotes (1)
- [F1]Such option will become exercisable monthly in substantially equal installments over one year, beginning from the date of grant (March 13, 2025), with the final monthly installment vesting on the nearest trading day on the Nasdaq Global Select Market preceding the 2026 annual meeting of stockholders.
Issuer
ENANTA PHARMACEUTICALS INC
CIK 0001177648
Entity typeother
Related Parties
1- filerCIK 0001236389
Filing Metadata
- Form type
- 4
- Filed
- Mar 13, 8:00 PM ET
- Accepted
- Mar 14, 5:34 PM ET
- Size
- 8.6 KB